27 Mar, 2020

Balancing scientific rigour with speed in race to find COVID-19 treatment

March 27th, 2020|Categories: Articles|

Mar 27, 2020 By The National Observer This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, gray, cultured in the lab. File photo/AP, NIAID-RML Researchers in the race against time to provide a proven treatment [...]

17 Feb, 2020

A smart future

February 17th, 2020|Categories: Articles|

Jan 23, 2020 By Pharmatimes Like it or not, artificial intelligence (AI) has already begun to reshape the way pharma and biotech companies operate at almost every level. The integration of AI-based data analysis into the entire spectrum of these companies’ activities has led to increasing collaboration with AI developers, and we expect this trend [...]

29 Jan, 2020

Manufacturing medicines in space: how astronauts will make their own drugs.

January 29th, 2020|Categories: Articles|Tags: , , |

Aug 22, 2019 By Allie Nawrat Pharmaceutical Technology NASA’s TRISH has funded innovative projects seeking to better protect astronauts' health during deep space missions. Two of the six projects focus on ‘just-in-time’ medications, which allow drugs to be manufactured on-demand and on-board the spacecraft. Allie Nawrat talks to the TRISH scientist Dr Emmanuel Urquieta about [...]

23 Dec, 2019

Leading the way: How the Pharmaceutical industry can benefit from digital transformation with a new strategic approach for Publication Planning.

December 23rd, 2019|Categories: Blog|Tags: , , , , |

There is an increasing need to quickly publish emerging clinical evidence supporting novel treatments and medications and extend the reach of key medical claims to new target audiences. You may also like: Why You Need a Medical Communications Company for Publication Planning. It’s estimated $58.8 billion USD is invested every year in R&D by pharma [...]

11 Dec, 2019

The Rise and Rise of Patient Centricity

December 11th, 2019|Categories: Articles|Tags: , , |

Aug 22, 2019 By George Underwood Pharmaphorum George Underwood looks at the rapid growth of patient centricity over the last few years and considers what pharma’s next steps should be to enhance patient engagement. I still consider myself a relative newbie to the pharma industry, having only started seriously covering the sector five years ago. [...]

10 Dec, 2019

The Digital Learning Revolution: How Classes are Moving Out Of The Classroom

December 10th, 2019|Categories: Articles|

Nov 28, 2019 By Enterpreneuer.com Every learning process has two principal stakeholders—students and teachers, or as we like to call them learners and helps—and two fundamental engagement tools, questions and answers. Learning processes essentially can be centered on either the teacher or the student, but the outcomes they result in are drastically different. The didactic [...]

8 Dec, 2019

Four digital health trends set to reinvent and re-energise pharma.

December 8th, 2019|Categories: Articles|

Dec 05, 2019 By Digital Inteligence Blog Why AI is set to transform the nature of healthcare. When British Secretary of State for Health and Social Care Matt Hancock addressed the Public Health England annual conference in September, his speech provided valuable backing for the prediction that AI is set to transform the nature of [...]

7 Dec, 2019

Where next for patient centricity in pharma?

December 7th, 2019|Categories: Articles|

Nov 08, 2019 By Paul Tunnah Pharmaphorum As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need to consider to deliver on its promises. There has been a marked elevation of noise around ‘patient centricity’ in recent years, with most pharma companies featuring the word ‘patient’ in [...]